Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Companyâs Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Companyâs Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļALC
āļāļ·āđāļāļāļĢāļīāļĐāļąāļAlcon AG
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 09, 2019
āļāļĩāļāļĩāđāļEndicott (David J)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ25599
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļApr 09
āļāļĩāđāļāļĒāļđāđRue Louis d'Affry 6
āđāļĄāļ·āļāļFRIBOURG
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻSwitzerland
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ1700
āđāļāļĢāļĻāļąāļāļāđ41589113800
āđāļ§āđāļāđāļāļāđhttps://www.alcon.ch/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļALC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļApr 09, 2019
āļāļĩāļāļĩāđāļEndicott (David J)
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
Ms. Karen J. May, CPA
Independent Director
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Mr. Scott Harlan Maw
Independent Director
Ms. Ines Poeschel
Independent Director
Ms. Lynn Dorsey Bleil
Independent Director
Ms. Deborah Di Sanzo
Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
Ms. Karen J. May, CPA
Independent Director
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Global X Aging Population ETF
Franklin FTSE Switzerland ETF
iShares MSCI Switzerland ETF
First Trust Indxx Medical Devices ETF
Running Oak Efficient Growth ETF
Global X S&P Catholic Values Developed ex-US ETF
JPMorgan BetaBuilders Europe ETF
iShares Global Healthcare ETF
ALPS O'Shares International Developed Quality Dividend ETF
Wahed Dow Jones Islamic World ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Global X Aging Population ETF
āļŠāļąāļāļŠāđāļ§āļ2.36%
Franklin FTSE Switzerland ETF
āļŠāļąāļāļŠāđāļ§āļ2.28%
iShares MSCI Switzerland ETF
āļŠāļąāļāļŠāđāļ§āļ2.2%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ2.06%
Running Oak Efficient Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.77%
Global X S&P Catholic Values Developed ex-US ETF
āļŠāļąāļāļŠāđāļ§āļ1.07%
JPMorgan BetaBuilders Europe ETF
āļŠāļąāļāļŠāđāļ§āļ0.59%
iShares Global Healthcare ETF
āļŠāļąāļāļŠāđāļ§āļ0.53%
ALPS O'Shares International Developed Quality Dividend ETF
āļŠāļąāļāļŠāđāļ§āļ0.45%
Wahed Dow Jones Islamic World ETF
āļŠāļąāļāļŠāđāļ§āļ0.44%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
400.00M
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021